Classifying MMR variants: time for revised nomenclature in Lynch syndrome

Clin Cancer Res. 2013 May 1;19(9):2280-2. doi: 10.1158/1078-0432.CCR-13-0392. Epub 2013 Mar 26.

Abstract

Inactivating germline mutations in DNA mismatch repair (MMR) genes are diagnostic for Lynch syndrome. However, the clinical significance of missense variants is uncertain. A threshold level of compromised MLH1 expression, correlating with greater protein instability and MMR functional defect, has been identified to help classify the pathogenicity of missense variants.

Publication types

  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Adaptor Proteins, Signal Transducing / genetics*
  • Colorectal Neoplasms, Hereditary Nonpolyposis / diagnosis*
  • Humans
  • MutL Protein Homolog 1
  • Nuclear Proteins / genetics*

Substances

  • Adaptor Proteins, Signal Transducing
  • MLH1 protein, human
  • Nuclear Proteins
  • MutL Protein Homolog 1